700089P
Avanti
Atheronal B
Avanti Research™ - A Croda Brand
Synonym(s):
3β,5β-dihydroxy-B-norcholestane-6β-carboxaldehyde
Sign Into View Organizational & Contract Pricing
Select a Size
About This Item
Empirical Formula (Hill Notation):
C27H46O3
Molecular Weight:
418.65
UNSPSC Code:
12352211
NACRES:
NA.25
Assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 1 mg (700089P-1mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand
shipped in
dry ice
storage temp.
−20°C
General description
Atheronal molecules may be a new association, in the already complex inter-relationship, between inflammation, cholesterol oxidation, the tissue macrophage, and atherosclerosis.
Atheronal-B is generated by the intramolecular aldolization of atheronal-A and this interconversion is rapid. It is present in plasma and is well detectable. Atheronal A and B are also referred to as cholesterol 5,6-secosterols.
Biochem/physiol Actions
Atheronal-B levels are elevated in patients with cardiovascular disease like atherosclerosis. Atheronal A and B favor misfolding of α-synuclein, apolipoprotein-B100 and β-amyloid by adding an aldehyde group to the lysine side chain. In addition, atheronals also modify the cationic property of myelin basic protein (MBP) leading to structural change, which contributes directly to the pathogenesis of multiple sclerosis.
Packaging
5 mL Amber Glass Screw Cap Vial (700089P-1mg)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
No data available
Flash Point(C)
No data available
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Cindy Takeuchi et al.
Biochemistry, 45(23), 7162-7170 (2006-06-07)
The proatherogenic properties of the cholesterol 5,6-secosterols (atheronal-A and atheronal-B), recently discovered in atherosclerotic arteries, have been investigated in terms of their effects on monocyte/macrophage function. A fluorescent analogue of atheronal-B (1) (50 microM), when cultured in either aqueous buffer
Natalie K Cygan et al.
Biochemistry, 50(12), 2092-2100 (2011-02-15)
Myelin degradation in the central nervous system (CNS) is a clinical hallmark of multiple sclerosis (MS). A reduction in the net positive charge of myelin basic protein (MBP) via deimination of arginine to citrulline has been shown to correlate strongly
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service